Concepedia

Author

John E. Levine

University of MichiganORCID

Also Known As

J E Levine, J LEVINE, J Levine, J. E. Levine, J. Levine, J.E. Levine, JE Levine, John E Levine, John E. Levine, John Levine

391

Publications

19.5K

Citations

66

H-Index

125

Concepts

All Affiliations

University of MichiganIcahn School of Medicine at Mount SinaiUniversity of PennsylvaniaFred Hutch Cancer CenterChildren's Hospital of Philadelphia
JE

About

John E. Levine is an author at University of Michigan specializing in medicine, transplantation, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

40

3.8K

2

Health Sciences

10

10

1.3K

3

Education

1

1

16

4

Engineering

1

1

24

5

Public Health

1

1

24

John E. Levine

×

138

Publications

14.9K

Citations

61

H-Index

YearCitations

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Andrew C. Harris, Rachel Young, Steven M. Devine,

Biology of Blood and Marrow Transplantation

2015

882

Recombinant human acid α-glucosidase

Priya S. Kishnani, Deya Corzo, Marc Nicolino,

Neurology

2006

759

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando, Xia Han, Catherine Tribouley,

Nature Medicine

2018

542

Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease

Ernst Holler, Peter Butzhammer, Karin Schmid‐Zalaudek,

Biology of Blood and Marrow Transplantation

2014

516

EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

Hélène Schoemans, Stephanie J. Lee, James L.M. Ferrara,

Bone Marrow Transplantation

2018

460

Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth

Rajen Mody, Yi-Mi Wu, Robert J. Lonigro,

JAMA

2015

408

A biomarker panel for acute graft-versus-host disease

Sophie Paczesny, Oleg I. Krijanovski, Thomas Braun,

Blood

2008

397

ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

Mark T. Vander Lugt, Thomas Braun, Samir Hanash,

New England Journal of Medicine

2013

391

Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency.

Daniel Williams, Feng‐Chun Yang, Chaekyun Kim,

PubMed

2000

339

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

James L.M. Ferrara, Andrew C. Harris, Joel K. Greenson,

Blood

2011

324

Page 1